awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48401064-11EDEE47-C96E-4049-AAAD-5AA99B0433AE
Q48401064-11EDEE47-C96E-4049-AAAD-5AA99B0433AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48401064-11EDEE47-C96E-4049-AAAD-5AA99B0433AE
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
P356
Q48401064-11EDEE47-C96E-4049-AAAD-5AA99B0433AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48401064-11EDEE47-C96E-4049-AAAD-5AA99B0433AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa31f329697b8bc6ac8abcdb69efff22a6683840
P356
10.1093/ANNONC/MDU577
http://www.w3.org/2001/XMLSchema#string
P356
MDU577